EMMA Projected Dividend Yield
Emmaus Life Sciences Inc (New) ( OTCBB : EMMA )Emmaus Life Sciences is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of treatments and therapies, primarily for rare and orphan diseases. Co.'s primary product, Endari® (prescription grade L-glutamine oral powder) is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Co. is also party to an early access agreement with a partner in the European Union (EU) pursuant to which Co.'s partner distributes Endari® on an early access basis only in France and certain other EU member states. 20 YEAR PERFORMANCE RESULTS |
EMMA Dividend History Detail EMMA Dividend News EMMA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |